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Coronavirus — preventing an occupational hazard among doctors
To the Editor
It all started in the last week of December 
2019 when the World Health Organization (WHO) 
was alerted regarding several respiratory infec-
tions localized to a city in China. In January 2020, 
China confirmed a new virus, the Novel Corona-
virus (nCoV), and the resulting disease was later 
termed COVID-19 (Coronavirus disease 2019). 
Since then, the spread, incidence, and death toll 
has taken a draconian leap with cases reported 
from over 4 continents with countries including 
China, Thailand, Hong Kong, Australia, Taiwan, 
Singapore, Malaysia, Japan, Canada, and Germa-
ny just to name a  few.  India has also reported 
over 100 confirmed cases as of March 16th, 2020 
and the numbers are rising.
The reasons for COVID-19 quickly becoming 
a pandemic are numerous and include but are 
not limited to the following: a late reaction from 
public health agencies, an unrestricted flow of 
people across various borders, human to human 
spread even during incubation periods, and non-
-specific symptoms including fever, running nose, 
cough, breathlessness and headache.
Health care personnel including doctors are 
directly exposed during detection, isolation, and 
treatment of patients and contacts. In a resource 
constrained setting, this has the potential to turn 
into an occupational hazard [1]. The situation is 
further compounded by the fact that a vaccine 
may be at least one to two years away, even though 
trials for 35 vaccine candidates are planned for 
commencement. However, there are a few simple 
yet effective steps which can easily reduce this 
risk [2, 3].
Hand hygiene — it’s in your hands now
In a  time when the general public is mass 
buying masks and other preventive gear, it is the 
duty and right of every health care worker (HCW) 
to use them during the entire time spent in contact 
with patients or contacts. The advantages are many 
and include a decreased risk of infection, decre-
ased risk of spread to one’s family, and a decreased 
risk of spread to other patients. Hand sanitizers and 
hand washing practices followed in operation the-
atres and intensive care units have to be ensured 
and used in all areas of the hospital. Hand hygiene 
(HH) should be performed before and after any 
contact with patients. If alcohol-based hand rubs 
are used, the concentration should be ensured to 
include > 60% alcohol. If hands are visibly soiled, 
soap and water should be used [3–5]. 
Personal protective equipment — your very own 
security shield
Ensure that hand hygiene has been performed 
before donning (putting on) personal protective 
equipment (PPE). If a respirator (N95 respirator) is 
not available, a facemask should be used. For eye 
protection, goggles or face shields can be employ-
ed. It should be remembered that refractive-error 
correcting personal glasses do not qualify as eye 
protective gear. Further, care should be given to-
wards not touching the eye/face protection or ma-
sks. Other important points to note regarding PPE 
include: not wearing a facemask inside an N95 
respirator (as the former loosens it and renders 
it useless), doffing (removing PPE) in the order 
of glove, goggle, gown and mask, and performing 
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immediate hand hygiene after doffing. In case of 
a shortage of facemasks or eye protection gear, 
centres for disease control and prevention (CDC) 
advises changing gloves and gown (in addition 
to HH) while keeping the same facemask and 
eye protection gear between patients which have 
the same diagnosis [4, 5]. Diagnostic specimens 
should preferably be collected by dedicated col-
lection teams, and team members should wear 
a respirator in addition to PPEs. 
Segregation of hospital staff and doctors — 
divide to prevent I
It may be difficult in view of limited staff, ho-
wever, every attempt should be made to designate 
health-care teams dedicated to COVID-19 patient 
care during a single shift. Adequate training for 
PPE, sample collection, and waste disposal of 
personnel caring for COVID-19 patients should be 
mandatory for all HCWs. Further, it is important to 
have control checks on the shift hours and number 
of shifts to ensure adequate rest and avoid phy-
sician fatigue. As well, providing emotional sup-
port cannot be overstated in these testing times. 
Changing to hospital scrubs at the time of starting 
a shift may also contribute to prevention. HCWs 
should be advised to immediately report if they 
develop COVID-19 symptoms. Additionally, they 
should be actively monitored for these symptoms. 
The CDC has recently published interim guidance 
on the identification of the risk-level of HCWs [6].
Patient segregation — divide to prevent II
COVID-19 patients requiring admission 
should be provided with a single room or a common 
room with at least 1m distance between patients. 
Hospitals must ensure that the block handling 
COVID-19 patients has separate entry/exit points, 
ventilation, and waste management from the rest 
of the hospital to avoid spreading to health care 
workers not working in other areas of the hospital. 
All individuals entering the block should adhere 
to strict HH/PPE guidance. Suspected/confirmed 
COVID-19 patients should be advised to wear a fa-
cemask as a source control measure to decrease 
droplet and secretion emission. In case of a shor-
tage of facemasks, patients should be advised to 
use tissues, handkerchiefs or cloth masks to cover 
their mouth and nose, in addition to maintaining 
strict cough etiquette and respiratory hygiene. 
Engineering controls like proper ventilation of 
patients rooms with at least 12 air circulation 
per hour can decrease droplet concentration and 
thus, decrease contamination of surfaces when 
these droplets settle. Either mechanical or natu-
ral ventilation can be employed but never both 
together. Further details can be accessed in WHO 
documents [2, 5].
Patient transport outside of the COVID-19 block 
should be minimized to reduce contact with non-
-COVID-19 medical staff. Lastly, early recognition 
and transfer of patients from non-Covid-19 wards 
or emergency wards should also be employed.
Additional precautions during aerosol generating 
procedures
Procedures like induction of sputum, bron-
choscopy, nebulization, non-invasive ventilation 
(NIV), endotracheal intubation/extubation, open 
endotracheal suction, open tracheostomy etc. 
generate aerosols and droplets. In addition to the 
usual precautions, HCWs should use particula-
te respirators (e.g. N95 respirator). All patient 
procedures should be performed preferably in 
the patient’s room. In case this is not possible, 
a dedicated room in the COVID-19 block should 
be used to avoid exposure of non-COVID-19 
staff. Additionally, in the case of the latter, room 
surfaces should be disinfected between patients. 
Cheung et al. recommend using rapid sequence in-
duction for COVID-19 patients wherever Invasive 
Mechanical Ventilation is required [7]. They do not 
recommend using NIV or high flow nasal oxygen 
(HFNO) until the patient is cleared of COVID-19. 
However, the strength of these recommendations 
needs to be assessed in planned clinical trials. 
A few more points to remember regarding invasive 
mechanical ventilation include using a viral filter 
during bag and mask ventilation, using a video 
laryngoscope in place of a direct laryngoscope, 
and using closed endotracheal suctioning. 
Visitor check
A check on the number of visitors to patients 
admitted in the non-Covid-19 wards should not 
be forgotten during the community transmission 
part of a respiratory epidemic. An infected visi-
tor can easily infect patients, other visitors, and 
HCWs. Ideally, all visitors should be actively 
assessed for Covid-19 symptoms. 
Avoid public gathering — practice what you 
preach
All HCWs should practice universal preventi-
ve measures like avoiding crowded public places/ 
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/transport, non-essential travel, etc. Practicing 
‘social-distancing’ as much as possible could be 
an effective method in the prevention of airborne 
infection transmission [8].
Public education — preach what you practice
Hospitals should display posters and videos 
with instructions on HH and cough etiquette for 
visitors and patients alike throughout the whole 
hospital. In terms of limiting the community 
transmission phase of the epidemic, patients 
should be enquired about symptoms of COVID-19 
at the time of appointment scheduling in order to 
ensure minimizing the exposure of non-COVID-19 
HCWs. Additionally, since it may be difficult to 
screen patients at the time of first contact during 
emergency department (ED) visits, ED-HCWs sho-
uld use preventive measures universally. 
Looking to the future 
We should take advantage of technology as 
much as possible. Smartphones and tablet com-
puters can easily be employed for telemedicine 
and are already being put into practice at certain 
institutions around the world [5, 9].Tablet com-
puters may be used to interview patients during 
their hospital visits or even before they arrive 
at the hospital. This can lead to easy and early 
segregation of patients.
The quest for a vaccine is already underway 
with some experts even calling for simultaneous 
clinical and pre-clinical trials. A Phase-I clini-
cal trial is already underway [10]. Pharmacolo-
gists and molecular experts around the world 
are working hard to find a  cure. Even so, we 
must not forget that such solutions will take 
time. When these do become available, national 
health administrators must ensure early access 
for HCWs. 
Conclusion
The cocktail of high infectivity, a massive 
susceptible population, and the lack of a pre-
ventive vaccine or therapeutic drug has brought 
an unfortunate realization to long term fears of 
many health care experts. It has reminded us that 
the medical profession needs to push its limits 
further and faster than ever before to overcome 
this obstacle. As is the case with any pandemic, 
the healthcare infrastructure will be put through 
a cauldron and will be stretched to its thinnest 
limit. While the world measures us with their 
own yardstick, we must not forget that our own 
well-being is important to ensure the well-being 
of the world around us. 
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